MIKA SACHS: Open Payments
NPI 1790151264 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,886 in 73 payments from 20 companies in 2025. Trend: 2023 $1,515 · 2024 $2,222 · 2025 $1,886
Food & beverage: $1,791Education: $95
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $422 |
| ABBVIE INC. | 12 | $215 |
| Regeneron Healthcare Solutions, Inc. | 6 | $161 |
| Amgen Inc. | 6 | $148 |
| UCB, Inc. | 5 | $142 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $118 |
| LEO Pharma Inc. | 5 | $91 |
| Galderma Laboratories, L.P. | 5 | $86 |
| Incyte Corporation | 3 | $76 |
| Organon LLC | 3 | $75 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, RINVOQ, OPZELURA, NEMLUVIO, ADBRY, OTEZLA.
Industry payments across MI — which companies pay providers there.
